According to Cocrystal Pharma
's latest financial reports the company has โน0.60 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โน2.19 B | -28.62% |
2022-12-31 | โน3.07 B | -29.66% |
2021-12-31 | โน4.36 B | 80.99% |
2020-12-31 | โน2.41 B | 356.37% |
2019-12-31 | โน0.52 B | 177.83% |
2018-12-31 | โน0.19 B | 298.65% |
2017-12-31 | โน47.76 M | -80.5% |
2016-12-31 | โน0.24 B | -60.26% |
2015-12-31 | โน0.61 B | 63.61% |
2014-12-31 | โน0.37 B | 489.82% |
2013-12-31 | โน63.88 M | 14301.97% |
2012-12-31 | โน0.44 M | -97.99% |
2011-12-31 | โน22.02 M | 95.45% |
2010-12-31 | โน11.26 M | 464.06% |
2009-12-31 | โน1.99 M | -44.28% |
2008-12-31 | โน3.58 M | -16.84% |
2007-12-31 | โน4.31 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Merck MRK | โน803.57 B | 133,233.33% | ๐บ๐ธ USA |
![]() USANA USNA | โน15.64 B | 2,495.19% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | โน3.377 T | 560,238.10% | ๐บ๐ธ USA |
![]() Nature's Sunshine Products NATR | โน7.53 B | 1,149.62% | ๐บ๐ธ USA |